Intrinsic Value of S&P & Nasdaq Contact Us

MedTech Acquisition Corporation MTAC NASDAQ

NASDAQ Capital Marke • Financial Services • Shell Companies • US • USD

SharesGrow Score
34/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — MTAC

MedTech Acquisition Corporation (MTAC) has a market capitalization of $83.86M and trades at $11.34. The 52-week range is 8.43-12.8299.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6.2, Earnings Per Share (EPS) of $-1.84, annual revenue of $45.15M.

The stock has a beta of -0.02, operates in the Financial Services sector.

Trading Data
Current Price$11.34
52-Week Range8.43-12.8299
Volume176.27K
Avg Volume (30D)13.97K
Market Cap$83.86M
Beta (1Y)-0.02
Company
IPO Date2021-02-08
CEOChristopher C. Dewey
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS58507N1054
CUSIP58507N105
Income (Latest Year)
Revenue$45.15M
Gross Profit$38.19M
EBITDA$-26.95M
Operating Income$-26.95M
Net Income$-69.69M
EPS$-1.84
EPS Diluted$-1.84
Shares Outstanding$37.9M
Balance Sheet (Latest Year)
Total Assets$35.33M
Current Assets$32.24M
Cash & ST Investments$20.44M
Total Liabilities$69.19M
Total Debt$34.44M
Net Debt$14M
Total Equity$-33.86M
Debt / Equity-1.02
Valuation Ratios
P/E Ratio-6.2
P/S Ratio1.86
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message